SciELO - Scientific Electronic Library Online

 
vol.134 issue5Recurrent left atrial myxoma. Report of a case in a 2 year-old boyOxidative stress in critically ill patients author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Revista médica de Chile

Print version ISSN 0034-9887

Abstract

RIGOTTI R, Attilio; ARTEAGA LL, Antonio  and  MAIZ G, Alberto. Intensive cholesterol lowering therapy to reduce cardiovascular risk. Rev. méd. Chile [online]. 2006, vol.134, n.5, pp.641-648. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872006000500014.

Primary and secondary prevention trials have clearly demonstrated that lowering serum cholesterol levels with statins reduces the incidence of cardiovascular events. Recent studies plus post hoc analysis of previous clinical trials show that risk reduction is proportional to the magnitude of LDL cholesterol lowering. Therefore, new recommendations of the National Cholesterol Education Program (USA) have defined a category of patients with very high cardiovascular risk, who should achieve serum LDL cholesterol levels below 70 mg/dl. This proposal will require new and more efficient pharmacologic strategies to attain the increasingly strict therapeutic goals for LDL cholesterol. This article reviews the clinical studies that support the use of intensive lipid lowering therapy to reduce cardiovascular risk. An effective reduction of serum cholesterol can be obtained using statins in high doses or a combination of hypolipidemic drugs with different mechanisms of action

Keywords : Hydroxymethylglutaryl-CoA reductase inhibitors; Hypercholesterolemia.

        · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License